These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24679075)

  • 21. Acute pancreatitis in children from Valproic acid: case series and review.
    Grauso-Eby NL; Goldfarb O; Feldman-Winter LB; McAbee GN
    Pediatr Neurol; 2003 Feb; 28(2):145-8. PubMed ID: 12699868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature.
    Gerstner T; Büsing D; Bell N; Longin E; Kasper JM; Klostermann W; Hebing B; Hanefeld F; Eckel U; Hoffmann R; Bettendorf U; Weidner B; Wiemer-Kruel A; Brockmann K; Neumann FW; Sandrieser T; Wolff M; König S
    J Gastroenterol; 2007 Jan; 42(1):39-48. PubMed ID: 17322992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VPA-induced recurrent pancreatitis in a cystic fibrosis carrier.
    Dinopoulos A; Karapanou O; Alexopoulou E; Tzetis M; Attilakos A; Fretzayas A
    Eur J Paediatr Neurol; 2011 Sep; 15(5):453-5. PubMed ID: 21778093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
    Reynolds MF; Sisk EC; Rasgon NL
    Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid-induced pancreatitis in a 15-year-old boy with juvenile myoclonic epilepsy.
    Veri K; Uibo O; Talvik I; Talvik T
    Medicina (Kaunas); 2013; 49(11):487-9. PubMed ID: 24823930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute childhood pancreatitis caused by valproate].
    Jakobović J; Butković D; Popović L; Skarić I; Mikecin L
    Lijec Vjesn; 2009; 131 Suppl 3():8-10. PubMed ID: 23120843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults.
    Buzan RD; Firestone D; Thomas M; Dubovsky SL
    J Clin Psychiatry; 1995 Nov; 56(11):529-32. PubMed ID: 7592507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of valproate in metabolic disturbances in bipolar disorder patients.
    Chang HH; Yang YK; Gean PW; Huang HC; Chen PS; Lu RB
    J Affect Disord; 2010 Aug; 124(3):319-23. PubMed ID: 20060174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of chronic pancreatic insufficiency due to valproic acid in a child.
    Cooper MA; Groll A
    Can J Gastroenterol; 2001 Feb; 15(2):127-30. PubMed ID: 11240383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
    Yokoyama S; Yasui-Furukori N; Nakagami T; Miyazaki K; Ishioka M; Tarakita N; Kubo K; Sugawara N; Shimoda K
    Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The difficulties of diagnosing VPA-induced pancreatitis in children with severe motor and intellectual disabilities.
    Yoshikawa H
    Eur J Paediatr Neurol; 2004; 8(2):109-10. PubMed ID: 15253060
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term use of valproic acid and the prevalence of cancers in bipolar disorder patients in a Taiwanese population: An association analysis using the National Health Insurance Research Database (NHIRD).
    Lin CC; Hsieh TC; Wu LS
    J Affect Disord; 2018 May; 232():103-108. PubMed ID: 29481993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
    Gentile S
    CNS Spectr; 2014 Aug; 19(4):305-15. PubMed ID: 24571806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
    Laghate VD; Gupta SB
    J Assoc Physicians India; 2004 Mar; 52():257-8. PubMed ID: 15636323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thinking out of the box: management of valproic acid toxicity with carbapenems.
    Sanivarapu R; Sharma R; Akella J
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33692057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.